MedTrace Logo

Role of Vitamin E in Gaucher Disease Patients

NCT06211478 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2024-01-18

No results posted yet for this study

Summary

gaucher disease (GD) can be classified into three clinical types .type 1,the most common type ,is the chronic non neuronpathic form of the disease,which shows gighly variable signs and symptoms and variable course,with visceral,skeletal and hematologic involvement among others.the neurologocal involvement can be observed in types 2 and 3

Conditions

  • Gaucher Disease

Interventions

DRUG

Vitamin E

Vitamin E will be taken for 6 months for gaucher disease patients who have oxidative stress and vitamin E defecient

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Amira A Adly, Phd · Ain Shams University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-03
Primary Completion
2023-09-05
Completion
2023-10-05

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06211478 on ClinicalTrials.gov